Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 7Uterine Cervical Neoplasms 5Leiomyoma 4Ovarian Neoplasms 3Myofibroma 3Uterine Neoplasms 2Carcinoma, Ovarian Epithelial 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Dysplasia 1Sarcoma 1Metrorrhagia 1Menorrhagia 1Hysterectomy 1Hereditary Breast and Ovarian Cancer Syndrome 1Fallopian Tube Neoplasms 1FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma 1Endometrial Hyperplasia 1Disease 1Carcinoma, Squamous Cell 1Carcinoma, Endometrioid 1Carcinoma, Adenosquamous 1Adenocarcinoma 1

Interventions

Radiotherapy, Intensity-Modulated 2Paclitaxel 2Cisplatin 2Carboplatin 2pembrolizumab 1fluoroazomycin arabinoside 1fludarabine phosphate 1fludarabine 1cabozantinib 1aldesleukin 1Panitumumab 1Nivolumab 1Metformin 1Interleukin-2 1Hysterectomy 1Fluorouracil 1Docetaxel 1Cyclophosphamide 1Chemoradiotherapy 1Cetuximab 1Albumin-Bound Paclitaxel 111-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4H-indazolo(5,4-a)pyrrolo(3,4-c)carbazol-4-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Adenosquamous × Hysterectomy × Clear all
NCT01363466 2011-06-01

Evaluation of Hysterectomy After Chemoradiation Therapy for Stage IB2/II Cervical Cancer

UNICANCER

Phase 3 Terminated
61 enrolled
Gynecologic

Adenocarcinoma, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡